We invest between £0.25 – 10 million
in fast growing businesses
Aridhia has built a sector-leading, differentiated informatics platform with cutting-edge analytical tools to support health care and research. It has established an international client base and a network of major strategic partners.
Cisiv is a leading provider of software for non-interventional studies for the pharmaceutical industry.
Exco InTouch is a leading electronic Patient Reported Outcomes and patient engagement software business.
Forward is a secure mobile messaging and workflow tool for doctors and care workers. They have established themselves as the leading secure mobile communication platform in the NHS.
Healios is an online platform delivering family centric psychological care primarily to children and adolescents. The Company provides assessment, treatment and early intervention for a variety of mental health conditions.
Locum's Nest is a web platform and mobile application which allows NHS Trusts to manage their requirements for Locum doctors in a more efficient and cost effective way.
Mirada Medical, a spin out from Siemens, has developed software that allows images from multiple sources to be combined to provide greater clinical certainty in diagnosis and treatment of cancer.
My Meds & Me provides a web-based solution for the capture of adverse events, product complaints and targeted medical information for pharmaceutical companies.
Odin Vision is developing the next generation of AI enabled applications for endoscopic procedures.
Oviva is a digital health business providing medical nutritional counselling. The company has developed mobile technology solutions that enable its dietitians to provide superior care in a highly efficient way.
Quell has been established with the aim of developing engineered T regulatory cell therapies. Quell will seek to utilise the power of Treg cells to advance therapies for the management and treatment of a range of solid organ transplant and autoimmune conditions.
Raremark, is a real-world data collection platform focused on rare diseases, their technology helps rare disease companies identify, engage and learn from patients, dramatically improving data collection to inform drug development.
uMotif provides a patient engagement and data capture platform for use in real world and observational research.
We back risk-takers and change-makers. Founders with a vision of the future and the determination to make it happen.
Albion Capital Group LLP is authorised and regulated by the Financial Conduct Authority.
Registered in England No. OC341254 Registered Office: 1 King's Arms Yard, London, EC2R 7AF. Member of the British Venture Capital Association